Kevin T. Nead, MD, MPhil
Department of Epidemiology, Division of Cancer Prevention and Population Sciences
Present Title & Affiliation
Primary Appointment
Member, Division of Cancer Prevention and Population Sciences, The University of Texas Graduate School of Biomedical Sciences, Houston, TX
Assistant Professor, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Member, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas
Assistant Professor, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
| 2014 | Stanford University School of Medicine, Stanford, California, US, MD |
| 2012 | University of Cambridge, Cambridge, GB, Epidemiology, MPhil (Masters) |
| 2008 | University of Florida, Gainesville, Florida, US, Zoology, BS |
Postgraduate Training
| 2015-2019 | Clinical Residency, Radiation Oncology, University of Pennsylvania Health System, Philadelphia, Pennsylvania |
| 2014-2015 | Clinical Internship, Internal Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania |
Licenses & Certifications
| 2021 | American Board of Radiology (Radiation Oncology) |
| 2019 | Texas Medical License |
Experience & Service
Other Professional Positions
Associate Fellow, Leonard Davis Institute of Health Economics, Philadelphia, PA, 2015 - 2019
Intramural Institutional Committee Activities
Member, Institutional Research Management Policy Guideline Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present
Co-Director, Seminar Series Committee, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Institute for Data Science in Oncology (IDSO) Internal Advisory Council (IAC), The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, MedTech Innovation Council, The University of Texas MD Anderson Cancer Center, 2024 - Present
Senator (Elected), Faculty Senate, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member (Elected), Physicians Referral Service Clinical Revenue Cycle Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present
Member, Department of Health Services Research Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Department of Epidemiology Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present
Chair, Translational Research Committee, Department of Breast Radiation Oncology, The University of Texas MD Anderson Cancer Center, 2022 - Present
Member, Division of Radiation Oncology Faculty Search Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Academic Review Committee for the Division of Education & Training, The University of Texas MD Anderson Cancer Center, 2020 - 2023
Director, Seminar Series Committee, Department of Epidemiology, The University of Texas MD Anderson Cancer Center, 2020 - 2024
Extramural Institutional Committee Activities
Member, Occupational Cancer Prevention Symposium Planning Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Voting Member, Appropriate Use Criteria Breast Committee, American Radium Society, 2021 - 2024
Honors & Awards
| 2025 | Leading Mentor in Cancer Prevention, Division of Cancer Prevention and Population Science, Nominated, The University of Texas MD Anderson Cancer Center |
| 2024 | ASTRO Annual Meeting Travel Award, Biology, ASTRO |
| 2024 | JACC CardioOnc’s Young Author Achievement Award (Mentor), American College of Cardiology |
| 2023 | Leading Mentor in Cancer Prevention, Division of Cancer Prevention and Population Science, The University of Texas MD Anderson Cancer Center |
| 2022 | Educator of the Year, Association of Residents in Radiation Oncology (ARRO) |
| 2018 | Conquer Cancer Foundation of ASCO Merit Award, The American Society of Clinical Oncology Foundation |
| 2018 | Charles J. Epstein Trainee Award for Excellence in Human Genetics Research - Finalist, American Society of Human Genetics |
| 2016 | B. Leonard Holman Research Pathway, The American Board of Radiology |
| 2013 | Travel Grant, Society for Vascular Medicine |
| 2013 | Kaiser Permanente of Northern California Medical Student Scholarship, Kaiser Permanente |
| 2013 | MacKenzie Foundation Scholarship, MacKenzie Foundation |
| 2013 | Young Investigator Award - Finalist, American College of Cardiology |
| 2012 | 1st in Class - GlaxoSmithKline Award, University of Cambridge |
| 2012 | American Heart Association Student Scholarship in Cardiovascular Disease and Stroke, American Heart Association |
| 2012 | Distinction in the MPhil thesis, examinations, and degree, University of Cambridge |
| 2012 | Scholar-in-Training Award, American Association for Cancer Research |
| 2011 | Gates-Cambridge Scholarship, Gates-Cambridge |
| 2010 - 2012 | Medical Scholars Research Fellowship, Stanford University |
| 2010 | Medical Student Research Fellowship, American Heart Association |
| 2008 | Postgraduate Scholarship, National Collegiate Athletic Association (NCAA) |
| 2008 | Summa Cum Laude, University of Florida |
| 2008 | United States Olympic Swimming Trials Qualifier, United States Olympics |
| 2008 | Academic-All American; First Team, Division I, National Collegiate Athletic Association (NCAA) |
| 2008 | Phi Beta Kappa, University of Florida |
| 2007 | Howard Hughes Medical Institute Undergraduate Research Fellowship, University of Florida |
| 2005 | United States Swimming National Championship Finalist, USA Swimming |
Grant & Contract Support
| Date: | 2025 - 2029 |
| Title: | Deciphering the role of GFPT2 in radiation-induced cardiovascular disease |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | R01HL179815 |
| Date: | 2025 - 2032 |
| Title: | The role of cancer in cardiovascular disease |
| Funding Source: | NIH/NHLBI |
| Role: | Co-I |
| ID: | R35HL176060 |
| Date: | 2025 - 2028 |
| Title: | Defining how cancer accelerates atherosclerosis by provoking intraplaque neovascularization |
| Funding Source: | American Heart Association |
| Role: | Mentor |
| ID: | 25CDA1452612 |
| Date: | 2025 - 2028 |
| Title: | Clonal hematopoiesis and toxicity from radiation therapy |
| Funding Source: | CPRIT |
| Role: | PI |
| ID: | RP250062 |
| Date: | 2024 - 2026 |
| Title: | Characterization and Prediction of Second-Generation Anti-Androgen Associated Neurotoxicity in Patients with Prostate Cancer |
| Funding Source: | Cancer Neuroscience Program, MD Anderson |
| Role: | PI |
| ID: | CNP129405 |
| Date: | 2021 - 2026 |
| Title: | Impact of clonal hematopoiesis mutations on toxicity and outcomes following oncologic therapy |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | K08CA263313 |
| Date: | 2021 - 2024 |
| Title: | Risk Factors and Mechanisms of Radiation-Induced Cardiovascular Disease |
| Funding Source: | Multidisciplinary Research Program (MRP) |
| Role: | Core Leader |
| ID: | RCTS#00059910 |
| Date: | 2020 - 2025 |
| Title: | Causes and consequences of clonal hematopoiesis mutations |
| Funding Source: | NIH/NCI (Loan Repayment Program) |
| Role: | PI |
| ID: | L30CA253796 |
| Date: | 2020 - 2022 |
| Title: | Defining acquired mutations in healthy breast tissue and their association with breast cancer risk factors and breast cancer risk |
| Funding Source: | Duncan Family Institute |
| Role: | PI |
| Date: | 2020 - 2021 |
| Title: | Clonal hematopoiesis among individuals with non-hematologic cancer: association with comorbid disease and treatment toxicity |
| Funding Source: | Conquer Cancer Foundation of ASCO |
| Role: | PI |
| Date: | 2019 - 2022 |
| Title: | Science and Technology Acquisition and Retention Program (STARs) |
| Funding Source: | University of Texas (UT) |
| Role: | PI |
| Date: | 2019 - 2025 |
| Title: | Recruitment of First-Time, Tenure-Track Faculty Members |
| Funding Source: | CPRIT |
| Role: | PI |
| ID: | RR190077 |
| Date: | 2019 - 2019 |
| Title: | Clonal hematopoiesis among individuals with non-hematologic cancer: association with comorbid disease and treatment toxicity |
| Funding Source: | Marlene Shlomchik Fellowship in Cancer Research; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine |
| Role: | PI |
| Date: | 2018 - 2019 |
| Title: | Risk of cancer in children among families known to carry BRCA1/2 mutations |
| Funding Source: | The Gerber Foundation |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Angelov I, Haas AM, Brock E, Luo L, Zhao J, Smith BD, Giordano SH, Leeper NJ, Nead KT. Cardiovascular Disease and Breast Cancer Stage at Diagnosis. JAMA Netw Open 8(1):e2452890, 2025. e-Pub 2025. PMID: 39745699.
- Navsaria LJ, Haas AM, Corredor JL, Arun BK, Giordano SH, Nead KT, Wehner MR. Skin cancer risk in patients with BRCA mutations. JAAD Int 17:175-177, 2024. e-Pub 2024. PMID: 39525845.
- Nead KT, Kim T, Joo L, McDowell T, Wong J, Chan IC, Brock E, Zhao J, Xu T, Tang C, Lee CL, Abe JI, Bolton KL, Liao Z, Scheet P, Lin SH. Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes. Blood Adv 8(19):5215-5224, 2024. e-Pub 2024. PMID: 38830141.
- Luo L, Haas AM, Bell CF, Baylis RA, Adkar SS, Fu C, Angelov I, Giordano SH, Klarin D, Leeper NJ, Nead KT. Cancer Incidence After Diagnosis of Abdominal Aortic Aneurysm. Arterioscler Thromb Vasc Biol 44(7):1694-1701, 2024. e-Pub 2024. PMID: 38779853.
- Bell CF, Lei X, Haas A, Baylis RA, Gao H, Luo L, Giordano SH, Wehner MR, Nead KT, Leeper NJ. Risk of Cancer After Diagnosis of Cardiovascular Disease. JACC CardioOncol 5(4):431-440, 2023. e-Pub 2023. PMID: 37614573.
- Nowakowska MK, Ortega RM, Wehner MR, Nead KT. Association of Second-generation Antiandrogens With Cognitive and Functional Toxic Effects in Randomized Clinical Trials: A Systematic Review and Meta-analysis. JAMA Oncol 9(7):930-937, 2023. e-Pub 2023. PMID: 37227736.
- Nead KT, Hinkston CL, Wehner M. Cautions When Using Race and Ethnicity in Administrative Claims Data Sets. JAMA Health Forum 3(7), 2022. e-Pub 2022. PMID: 36218996.
- Carey RM, Kim T, Cohen NA, Lee RJ, Nead KT. Impact of sweet, umami, and bitter taste receptor (TAS1R and TAS2R) genomic and expression alterations in solid tumors on survival. Sci Rep 12(1):8937, 2022. e-Pub 2022. PMID: 35624283.
- Nowakowska MK, Kim T, Thompson MT, Bolton KL, Deswal A, Lin SH, Scheet P, Wehner MR, Nead KT. Association of clonal hematopoiesis mutations with clinical outcomes: a systematic review and meta-analysis. Am J Hematol 97(4):411-420, 2022. e-Pub 2022. PMID: 35015316.
- Sosa A, Lei X, Woodward WA, Chavez Mac Gregor M, Lucci A, Giordano SH, Nead KT. Trends in Sentinel Lymph Node Biopsies in Patients With Inflammatory Breast Cancer in the US. JAMA Netw Open 5(2):e2148021, 2022. e-Pub 2022. PMID: 35147686.
- Nowakowska MK, Lei X, Wehner MR, Corn PG, Giordano SH, Nead KT. Association of Second-generation Antiandrogens with Depression Among Patients With Prostate Cancer. JAMA Netw Open 4(12):e2140803, 2021. e-Pub 2021. PMID: 34940861.
- Nowakowska MK, Lei X, Thompson MT, Shaitelman SF, Wehner MR, Woodward WA, Giordano SH, Nead KT. Association of statin use with clinical outcomes in patients with triple-negative breast cancer. Cancer 127(22):4142-4150, 2021. e-Pub 2021. PMID: 34342892.
- Nead KT, Hinkston CL, Linos E, Giordano SH, Wehner MR. American Board of Medical Specialties Board Examination Lactation Accommodation Policies. JAMA Intern Med 181(10):1397-1399, 2021. e-Pub 2021. PMID: 34180945.
- Arscott WT, Nead KT, Bear A, Venigalla S, Shabason J, Lukens JN, Plastaras JP, Wojcieszynski A, Metz J, O'Hara M, Reiss KA, Teitelbaum U, Loaiza-Bonilla A, Drebin J, Lee MK, Shroff SG, Ben-Josef E. Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer. Am J Clin Oncol 44(9):469-474, 2021. e-Pub 2021. PMID: 34310350.
- Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated Projection of US Cancer Incidence and Death to 2040. JAMA Netw Open 4(4):e214708, 2021. e-Pub 2021. PMID: 33825840.
- Thompson MR, Niu J, Lei X, Nowakowska M, Wehner MR, Giordano SH, Nead KT. Association of Endocrine Therapy and Dementia in Women with Breast Cancer. Breast Cancer (Dove Med Press) 13:219-224, 2021. e-Pub 2021. PMID: 33854369.
- Wehner MR, Li Y, Nead KT. Comparison of the Proportions of Female and Male Corresponding Authors in Preprint Research Repositories Before and During the COVID-19 Pandemic. JAMA Netw Open 3(9):e2020335, 2020. e-Pub 2020. PMID: 32940678.
- Nead KT, Mitra N, Weathers B, Pyle L, Emechebe N, Pucci DA, Jacobs LA, Vaughn DJ, Nathanson KL, Kanetsky PA. Lower abdominal and pelvic radiation and testicular germ cell tumor risk. PLoS One 15(11):e0239321, 2020. e-Pub 2020. PMID: 33175879.
- Nead KT, Swisher-McClure S. Utilization of hypofractionated radiation therapy in older glioblastoma patients. J Geriatr Oncol 10(1):155-158, 2019. e-Pub 2019. PMID: 30017732.
- Nead KT, Wehner MR, Mitra N. The Use of "Trend" Statements to Describe Statistically Nonsignificant Results in the Oncology Literature. JAMA Oncol 4(12):1778-1779, 2018. e-Pub 2018. PMID: 30347042.
- Nead KT, Boldbaatar N, Yang DD, Sinha S, Nguyen PL. Association of Androgen Deprivation Therapy and Thromboembolic Events: A Systematic Review and Meta-analysis. Urology 114:155-162, 2018. e-Pub 2018. PMID: 29352986.
- Venigalla S, Nead KT, Sebro R, Guttmann DM, Sharma S, Simone CB, Levin WP, Wilson RJ, Weber KL, Shabason JE. Association Between Treatment at High-Volume Facilities and Improved Overall Survival in Soft Tissue Sarcomas. Int J Radiat Oncol Biol Phys 100(4):1004-1015, 2018. e-Pub 2018. PMID: 29485042.
- Nead KT, Sinha S, Yang DD, Nguyen PL. Association of androgen deprivation therapy and depression in the treatment of prostate cancer: A systematic review and meta-analysis. Urol Oncol 35(11):664.e1-664.e9, 2017. e-Pub 2017. PMID: 28803700.
- Nead KT, Sinha S, Nguyen PL. Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 20(3):259-264, 2017. e-Pub 2017. PMID: 28349979.
- Wehner MR, Nead KT, Linos E. Correlation Among Cancer Incidence and Mortality Rates and Internet Searches in the United States. JAMA Dermatol 153(9):911-914, 2017. e-Pub 2017. PMID: 28658470.
- Wehner MR, Nead KT, Lipoff JB. Association Between Gender and Drug Cost for Over-the-Counter Minoxidil. JAMA Dermatol 153(8):825-826, 2017. e-Pub 2017. PMID: 28593214.
- Nead KT, Gaskin G, Chester C, Swisher-McClure S, Leeper NJ, Shah NH. Association Between Androgen Deprivation Therapy and Risk of Dementia. JAMA Oncol 3(1):49-55, 2017. e-Pub 2017. PMID: 27737437.
- Nead KT, Gaskin G, Chester C, Swisher-McClure S, Dudley JT, Leeper NJ, Shah NH. Influence of age on androgen deprivation therapy-associated Alzheimer's disease. Sci Rep 6:35695, 2016. e-Pub 2016. PMID: 27752112.
- Nead KT, Gaskin G, Chester C, Swisher-McClure S, Dudley JT, Leeper NJ, Shah NH. Androgen Deprivation Therapy and Future Alzheimer's Disease Risk. J Clin Oncol 34(6):566-71, 2016. e-Pub 2016. PMID: 26644522.
- Wehner MR, Nead KT, Linos K, Linos E. Plenty of moustaches but not enough women: cross sectional study of medical leaders. BMJ 351:h6311, 2015. e-Pub 2015. PMID: 26673637.
- Nead KT, Sharp SJ, Thompson DJ, Painter JN, Savage DB, Semple RK, Barker A, Group (ANECS) ANECS, Perry JR, Attia J, Dunning AM, Easton DF, Holliday E, Lotta LA, O'Mara T, McEvoy M, Pharoah PD, Scott RJ, Spurdle AB, Langenberg C, Wareham NJ, Scott RA. Evidence of a Causal Association Between Insulinemia and Endometrial Cancer: A Mendelian Randomization Analysis. J Natl Cancer Inst 107(9), 2015. e-Pub 2015. PMID: 26134033.
- Nead KT, Li A, Wehner MR, Neupane B, Gustafsson S, Butterworth A, Engert JC, Davis AD, Hegele RA, Miller R, den Hoed M, Khaw KT, Kilpeläinen TO, Wareham N, Edwards TL, Hallmans G, Varga TV, Kardia SL, Smith JA, Zhao W, Faul JD, Weir D, Mi J, Xi B, Quinteros SC, Cooper C, Sayer AA, Jameson K, Grøntved A, Fornage M, Sidney S, Hanis CL, Highland HM, Häring HU, Heni M, Lasky-Su J, Weiss ST, Gerhard GS, Still C, Melka MM, Pausova Z, Paus T, Grant SF, Hakonarson H, Price RA, Wang K, Scherag A, Hebebrand J, Hinney A, Japan B, AGEN-BMI, Consortium G, Franks PW, Frayling TM, McCarthy MI, Hirschhorn JN, Loos RJ, Ingelsson E, Gerstein HC, Yusuf S, Beyene J, Anand SS, Meyre D. Contribution of common non-synonymous variants in PCSK1 to body mass index variation and risk of obesity: a systematic review and meta-analysis with evidence from up to 331 175 individuals. Hum Mol Genet 24(12):3582-94, 2015. e-Pub 2015. PMID: 25784503.
- Myers J, Nead KT, Chang P, Abella J, Kokkinos P, Leeper NJ. Improved reclassification of mortality risk by assessment of physical activity in patients referred for exercise testing. Am J Med 128(4):396-402, 2015. e-Pub 2015. PMID: 25511076.
- Chang P, Nead KT, Olin JW, Myers J, Cooke JP, Leeper NJ. Effect of physical activity assessment on prognostication for peripheral artery disease and mortality. Mayo Clin Proc 90(3):339-45, 2015. e-Pub 2015. PMID: 25649965.
- Chang P, Nead KT, Olin JW, Cooke JP, Leeper NJ. Clinical and socioeconomic factors associated with unrecognized peripheral artery disease. Vasc Med 19(4):289-296, 2014. e-Pub 2014. PMID: 24872403.
- Dragoo JL, Wasterlain AS, Braun HJ, Nead KT. Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial. Am J Sports Med 42(3):610-8, 2014. e-Pub 2014. PMID: 24481828.
- Downing KP, Nead KT, Kojima Y, Assimes T, Maegdefessel L, Quertermous T, Cooke JP, Leeper NJ. The combination of 9p21.3 genotype and biomarker profile improves a peripheral artery disease risk prediction model. Vasc Med 19(1):3-8, 2014. e-Pub 2014. PMID: 24323119.
- Priest JR, Nead KT, Wehner MR, Cooke JP, Leeper NJ. Self-reported history of childhood smoking is associated with an increased risk for peripheral arterial disease independent of lifetime smoking burden. PLoS One 9(2):e88972, 2014. e-Pub 2014. PMID: 24558458.
- Nead KT, Cooke JP, Olin JW, Leeper NJ. Alternative ankle-brachial index method identifies additional at-risk individuals. J Am Coll Cardiol 62(6):553-9, 2013. e-Pub 2013. PMID: 23707317.
- Nead KT, Zhou M, Diaz Caceres R, Olin JW, Cooke JP, Leeper NJ. Walking impairment questionnaire improves mortality risk prediction models in a high-risk cohort independent of peripheral arterial disease status. Circ Cardiovasc Qual Outcomes 6(3):255-61, 2013. e-Pub 2013. PMID: 23633217.
- Nead KT, Zhou MJ, Caceres RD, Sharp SJ, Wehner MR, Olin JW, Cooke JP, Leeper NJ. Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography. Am J Cardiol 111(6):851-6, 2013. e-Pub 2013. PMID: 23290308.
- Cauchi S, Nead KT, Choquet H, Horber F, Potoczna N, Balkau B, Marre M, Charpentier G, Froguel P, Meyre D. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMC Med Genet 9:45, 2008. e-Pub 2008. PMID: 18498634.
Invited Articles
- Wehner M, Nead KT. Can Google help us fight cancer?. The lancet oncology 19(7):867, 2018. e-Pub 2018. PMID: 30084368.
Review Articles
- Joo L, Bradley CC, Lin SH, Scheet PA, Nead KT. Causes of Clonal Hematopoiesis: a Review. Curr Oncol Rep 25(3):211-220, 2023. e-Pub 2023. PMID: 36719597.
Editorials
- Neth BJ, Wefel JS, Nead KT. Cognitive outcomes in prostate cancer treatment: insights from the ODENZA trial and future considerations. Transl Androl Urol 14(4):864-867, 2025. PMID: 40376525.
- Wasserfall C, Nead K, Mathews C, Atkinson MA. The threshold hypothesis: solving the equation of nurture vs nature in type 1 diabetes. Diabetologia 54(9):2232-6, 2011. PMID: 21773685.
Patient Reviews
CV information above last modified September 16, 2025